These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 3016399)
1. [Effect of complamin on the levels of ACTH, cortisol and lipids in the blood of elderly patients with ischemic heart disease]. Gorbachev VV; Pristrom MS Kardiologiia; 1986 May; 26(5):30-3. PubMed ID: 3016399 [TBL] [Abstract][Full Text] [Related]
2. [Use of komplamin in chronic ischemic heart disease]. Serkova VK; Mikunis RI Vrach Delo; 1984 Nov; (11):16-8. PubMed ID: 6528554 [No Abstract] [Full Text] [Related]
3. Exercise training in ischemic heart disease: effect on physical performance and plasma lipids, ACTH, and cortisol. Cardús D; McTaggart WG; Ribas-Cardús F Arch Phys Med Rehabil; 1980 Jul; 61(7):303-10. PubMed ID: 6249235 [No Abstract] [Full Text] [Related]
4. [Effect of complamin and prodectin on microcirculation and lipid metabolism in psoriasis patients]. Rakhmatov AB; Bilash NV Vestn Dermatol Venerol; 1983 Apr; (4):15-8. PubMed ID: 6868813 [No Abstract] [Full Text] [Related]
5. [Rehabilitation course in patients with peripheral and coronary angio-organopathies. Studies with special reference to serum uric acid and cholesterol under xanthinol nicotinate]. Mensen H Ther Ggw; 1977 Oct; 116(10):1853-81. PubMed ID: 918880 [No Abstract] [Full Text] [Related]
6. [Evaluation of the efficacy of xavin treatment of ischemic heart disease]. Pomerantsev VP; Ivanova NA; Zadionchenko VS; Vertkin AL; Martynov AI Kardiologiia; 1978 Mar; 18(3):36-43. PubMed ID: 347136 [TBL] [Abstract][Full Text] [Related]
7. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis]. Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081 [No Abstract] [Full Text] [Related]
8. The effects of adrenocorticotrophic hormone and an equivalent dose of cortisol on the serum concentrations of lipids, lipoproteins, and apolipoproteins. Berg AL; Rafnsson AT; Johannsson M; Dallongeville J; Arnadottir M Metabolism; 2006 Aug; 55(8):1083-7. PubMed ID: 16839845 [TBL] [Abstract][Full Text] [Related]
9. [The effect of xanthinol nicotinate on the serum lipids and lipoproteins of patients with primary hyperlipoproteinemia Type IIb and IV]. Haacke H; Parwaresch MR; Mäder C Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():829-32. PubMed ID: 1029294 [No Abstract] [Full Text] [Related]
11. [Use of complamin in complex rehabilitation treatment of post-stroke patients of older age groups]. Man'kovskiĭ NB; Kostiuchenko VG; Tereshchenko LA Vrach Delo; 1978 Dec; (12):47-50. PubMed ID: 741723 [No Abstract] [Full Text] [Related]
12. [Use of xanthinol nicotinate in patients with chronic ischemic heart disease]. Sivkov II; Kukes VG; Borisov VG; Rudakov MA; Blistanova LS Ter Arkh; 1977; 49(1):30-3. PubMed ID: 867235 [No Abstract] [Full Text] [Related]
13. [Effect of fenicaberan and xavin on peripheral hemodynamic and blood coagulability indices in patients with chronic ischemic heart disease]. Shpak BIu; Neĭko EM; Debenklo MV; Lazho AS; Duma ZV Vrach Delo; 1988 Mar; (3):34-6. PubMed ID: 3394293 [No Abstract] [Full Text] [Related]
14. [Lipids in pregnant patients with severe course of gestosis treated with xanthinol nicotinate and bufenin hydrochloride]. Kuć A; Skrzydlewski Z Ginekol Pol; 1976 Apr; 47(4):379-82. PubMed ID: 177335 [No Abstract] [Full Text] [Related]
15. [Xantinol-nicotinate in primary type-V hyperlipoproteinaemia (author's transl)]. Haacke H; Parwaresch MR; Mäder C Dtsch Med Wochenschr; 1976 Sep; 101(39):1413-7. PubMed ID: 185036 [TBL] [Abstract][Full Text] [Related]
16. [Ergometric evaluation of treatment of ischemic heart disease with xavine]. Zadionchenko VS; Vertkin AL; Martynov AI; Panchenkova LA; Troshina EV Sov Med; 1978 Jan; (1):68-73. PubMed ID: 635674 [No Abstract] [Full Text] [Related]
17. [Therapeutic effect of complamine in atherosclerosis and ischemic heart disease]. Kalmykova VI; Aronchuk EK Sov Med; 1976 Jan; (1):113-8. PubMed ID: 1273633 [No Abstract] [Full Text] [Related]
18. [Effect of complamine on various indicators of hemostasis and microcirculation in chronic ischemic heart disease]. Bol'shakova RM; Dukhina MA; Furkalo NK; Solovtsova KM; Progonnaia VV Vrach Delo; 1978 Jan; (1):36-40. PubMed ID: 625941 [No Abstract] [Full Text] [Related]
19. [Treatment of chronic arterial vascular disorders with Complamin and Complamin retard]. Musil HE Med Welt; 1973 Jan; 24(3):103-13. PubMed ID: 4617835 [No Abstract] [Full Text] [Related]